819800-93-6Relevant articles and documents
SSTR5 ANTAGONISTS
-
Paragraph 00410, (2021/06/11)
This disclosure is directed, at least in part, to SSTR5 antagonists useful for the treatment of conditions or disorders involving the gut-brain axis. In some embodiments, the SSTR5 antagonists are gut-restricted compounds. In some embodiments, the condition or disorder is a metabolic disorder, such as diabetes, obesity, nonalcoholic steatohepatitis (NASH), or a nutritional disorder such as short bowel syndrome.
Method for taking DAST reagent as removing reagent to synthetize conjugated nitroolefin substituted series derivative
-
Paragraph 0066-0069, (2018/12/13)
The invention discloses a preparation method of taking a DAST reagent as a removing reagent to synthesize a conjugated nitroolefin substituted series derivative. The preparation method comprises the following steps that a carbonyl compound (compound II) i
COMPOUNDS AND METHODS FOR TREATING SYNOVIAL SARCOMAS
-
Page/Page column 45; 46, (2017/06/12)
The present invention includes compound and methods that are useful in treating certain cancers, such as synovial sarcomas.